Organized by:
ISD_Mainidentifier_RGB_transparent.fw.pn
MOTAC_Logo_Jata - EN.PNG
MSIDC logo transparent.fw.png
Supported by:
myceb_logo_180mm_FC_RGB.jpg
ISID Logo

9 Babcock Street, Unit 3

Brookline, MA 02446

United States

info@isid.org

Tel: +1 (617) 277-0551

Fax: +1 (617) 278-9113

  • White Facebook Icon
  • White Twitter Icon

© 2019 International Society for Infectious Diseases

SCIENTIFIC PROGRAM

*Scientific Program as of January 22

and is subject to change.
 

Download program overview: click here

Friday, February 21, 2020

......................................................................................................................................................................

 

MEET THE EXPERT

 

Urinary Tract Infections – Updates in Prevention and Management

Room: 302 & 303

Friday, February 21, 2020, 08:00 – 09:00 hrs

  


  • S. Roberts (New Zealand)

 

Meet the Editors 

Room: 304 & 305

Friday, February 21, 2020, 08:00 – 09:00 hrs

(In collaboration with Elsevier)


Co-chairs: J. McConnell (UK), R. Sarkar (UK)
 

  • International Journal of Infectious Diseases – E. Petersen (Denmark)

  • International Journal of Infectious Diseases – S. McLellan (USA)

  • The Lancet Digital Health – R. Sarkar (UK)

  • The Lancet Infectious Diseases – J. McConnell (UK)

  • Infectious Disease Cases – L. Lutwick (USA)

The Future of Rotavirus Vaccines: Novel Approaches to Increase Impact

Room: 301

Friday, February 21, 2020, 08:00 – 09:00 hrs

  


  • M. Santosham (USA)

  • C. Kirkwood (USA)

 

PLENARY

 

Plenary I
At the Forefront of Hepatitis C Virus Elimination

Room: Conference Hall 1-3

Friday, February 21, 2020, 09:15 – 10:00 hrs

Chair: R. Hajjeh (Egypt)

  • Malaysia’s Hepatitis C Elimination Journey – Global Impact and opportunity – Datuk Dr. Noor Hisham Abdullah (Malaysia)

  • Egypt's Experience in the Elimination of Hepatitis C – W. Doss (Egypt)

 

PARALLEL SYMPOSIA


 

Serosurveillance for Spillover of High Consequence Zoonotic Viruses at the Human-Animal Interface

Room: Conference Hall 1

Friday, February 21, 2020, 10:30 – 12:00 hrs

(In collaboration with EcoHealth Alliance)

Co-chairs: J. Epstein (USA), A. Hilmers (USA)

 

  • TBD

  • Bat Antibody Dynamics in Time: What Can We Learn about Pathogen Dynamics from Multiplexed Luminex Serological Assays – S. Seifert (Canada)

  • Serological Biosurveillance for Spillover of Henipaviruses and Filoviruses at Agricultural and Hunting Human-Animal Interfaces in Peninsular Malaysia – M.H. Lee (Malaysia)

Clinical Management of Hard to Treat Infections

Room: Conference Hall 2

Friday, February 21, 2020, 10:30 – 12:00 hrs

(In collaboration with the Malaysian Society of Infectious Diseases and Chemotherapy)

Co-chairs: Z. Sekawi (Malaysia), D. Lye (Singapore)

 

  • Management of Persistent MRSA Infections – P. Tambyah (Singapore)

  • Optimizing Management of Polymyxin Resistant Enterobacteriaceae – TBD

  • Treatment Options and the Role of PK/PD in Dose Optimization of Carbapenem-Resistant – S. M. S Lim (Australia)

 

Infectious Disease Innovations for a Digital World

Room: Conference Hall 3

Friday, February 21, 2020, 10:30 – 12:00 hrs

(In collaboration with Lancet ID and Lancet Digital Health)

Co-chairs: J. McConnell (UK), R. Sarkar (UK)
 

  • The Use of Mobile Phone Data for Outbreak Tracking – A. Wesolowski (USA)

  • Towards Data-Driven Decision-Making in Malaria: Digital and Genomic Tools – J. Gardy (United States)

  • A look into the Future - Using Digital Disease Surveillance Tools for Near Real-time Epidemic Forecasting – S. Bhatia (UK)
     

Oral Abstracts - Antimicrobial Use and Stewardship

Room: 302 & 303

Friday, February 21, 2020, 10:30 – 12:00 hrs

Co-chairs: A. Shibl (Saudi Arabia), TBD

  • Global antibiotic consumption: a modelling study - A. Browne (UNITED KINGDOM)

  • Current antimicrobial stewardship programmes in public sector facilities across South Africa: Has the National AMR Strategy Framework made an impact? - D. Engler (SOUTH AFRICA)

  • Investigating team dynamics and communication in surgical teams in relation to antibiotic prescribing and infection control - C. Bonaconsa (SOUTH AFRICA)

  • Recurrence of Clostridioides difficile infection: a multicenter study on incidence and risk factors - N. Petrosillo (ITALY)

  • Investigation of community-associated Clostridium (Clostridioides) difficile infections in the Asia-Pacific region, D. Collins (AUSTRALIA)

  • Antimicrobial use in two-week recall of febrile illness: A descriptive study based on Healthcare Utilization Survey in India - S. Thomas (INDIA)

  • Practice of over-the-counter dispensary of antibiotics for childhood illnesses in Addis Ababa, Ethiopia: a simulated patient encounter study - Tinsae Alemayehu (ETHIOPIA)

  • Antimicrobial prescribing trends and appropriateness in a tertiary teaching hospital in Malaysia - Ly Sia Loong (MALAYSIA)

 

HIV – Hot Topics 

Room: 304 & 305

Friday, February 21, 2020, 10:30 – 12:00 hrs

(In collaboration with the International AIDS Society)

Co-chairs: A. Kamarulzaman (Malaysia), W. Powderly (USA)
 

  • HIV Pre-Exposure Prophylaxis (PrEP) Updates for the Infectious Disease Physician – I. Azwa (Malaysia)

  • Same Day ART Initiation – R. Ramautarsing (Thailand)

  • Treatment of Latent TB Infection – S. Wasserman (South Africa)

 

WORKSHOP

 

The Guide to Infection Control in the Healthcare Setting

Friday, February 21, 2020, 12:30 – 13:45 hrs, Room: 302 & 303

 

G. Bearman (USA); M. Doll (USA); A. Desai (USA)

  • 12:30 to 12:45: Guide to Infection Control in the Healthcare Setting – Introduction and background

  • 12:45 to 12:50: International Society for Infectious Diseases - Position Papers - Implementing infection prevention and control measures across different resource settings

  • 12:50 to 13:25: We Need YOU – How to Get Involved

  • 13:25 to 13:45: What Can We Do to Make the Guide Better – Feedback Session

This workshop is open to registered Congress attendees at no additional cost. No pre-registration is necessary.

 

PARALLEL SYMPOSIA

Leadership Skills Development

Room: Conference Hall 1

Friday, February 21, 2020, 14:00 – 15:30 hrs
 

  • Presenting your Work: Storytelling Skills and Techniques to Make You a Great Presenter – K. Rebman (USA)

Debate: Antibiotics for Diarrheal Disease

Room: Conference Hall 2

Friday, February 21, 2020, 14:00 – 15:30 hrs

 

Debaters:

  • M. O’Ryan (Chile)

  • P. Ashorn (Finland)

 

Vaccines to Prevent Respiratory Disease Morbidity and Mortality 


Room: Conference Hall 3

Friday, February 21, 2020, 14:00 – 15:30 hrs

(In collaboration with the Bill & Melinda Gates Foundation)

Co-chairs: K. Klugman (USA), TBD

 

  • Vaccines to Prevent Respiratory Disease Morbidity and Mortality – K. Klugman (USA)

  • Introduction of and Access to PCV Vaccination in LMICs – B. Hausdorff (USA)

  • Lessons Learned from the Genomic Surveillance of Streptococcus pneumoniae – S. Lo (UK)

 

Oral Abstracts - Emerging, Re-Emerging, and Zoonotic Infections

Room: 302 & 303

Friday, February 21, 2020, 14:00 – 15:30 hrs

Co-chairs: B. Maiga (Mali), M. Pollack (USA)

  • In search for the hotspots of Disease X: A biogeographic approach to mapping the predictive risk of WHO’s Blueprint Priority Diseases - S. Jagadesh, (FRANCE)

  • What is the Best Way to Diagnose Dengue Haemorrhagic Fever Early? Routine Application of Ultrasound for Early Detection of Dengue Haemorrhagic Fever - L. Fernando (SRI LANKA)

  • Descriptive epidemiology of monkeypox in Nigeria, September 2017 - June 2019 - S. Akar (NIGERIA)

  • Exploring the burden of Ntwetwe virus – a novel orthobunyavirus associated with CNS infections – in Ugandan children - N. van den Brekel, (NETHERLANDS)

  • Circulation of Nipah virus at the human-Flying fox interface in Cambodia - V. Duong (CAMBODIA)

  • Molecular characterization of Acanthamoeba isolated from contact lens paraphernalia: An evidence of potentially pathogenic T4 genotype in Malaysia - R.H. Mohd Hussain (MALAYSIA)

  • A single amino acid substituion in NS5 protein enhances transplacental transsmission of Zika virus - C.F. Qin, (CHINA)

  • Puumala orthohantavirus genome sequence variations in the Republic of Tatarstan, Russia, - E. Kabwe (RUSSIAN FEDERATION)

Enterovirus Infections in Asia Pacific – Critical Updates 

Room: 304 & 305

Friday, February 21, 2020, 14:00 – 15:30 hrs

Co-chairs: K. K. Wong (Malaysia), R. Heyderman (UK)
 

  • Asia-Pacific Network for Enterovirus Surveillance Overview and Development of Enterovirus A71 Vaccines – M. Lee (Taiwan)

  • Laboratory Diagnosis and Management of Enterovirus Infections – Y. F. Chan (Malaysia)

  • Genetic and Antigenic Evolution of Enteroviruses in Asia Pacific – J. Phuenpa (Thailand)

 

PLENARY

 

Plenary II

Emerging Infectious Diseases Preparedness – Looking Through the One Health Lens


Room: Conference Hall 1-3

Friday, February 21, 2020, 16:00 – 17:00 hrs

Chair: J. Cohen (UK)

  • Pandemic Preparedness in China – G. Gao (China)

  • Climate Change, Migration and Infectious Diseases – K. Kumari Rigaud (USA)

  • Environmental Change and Emerging Infectious Diseases – P. Daszak (USA)

 

 

Saturday, February 22, 2020

......................................................................................................................................................................

 

MEET THE EXPERT


 

Surgical Site Infections – Updates in Prevention and Management


Room: 302 & 303

Saturday, February 22, 2020, 08:00 - 09:00 hrs

 

  • A. Holmes (UK), S. S. L. S. Ponnampalavanar (Malaysia)

 

A Career in Global Health and Public Health


Room: 304 & 305

Saturday, February 22, 2020, 08:00 - 09:00 hrs

 

  • R. Hajjeh (Egypt), W. N. W. Mohamed (Malaysia)

 

Innovative Solutions to Detect, Verify and Contain Outbreaks Faster


Room: 301

Saturday, February 22, 2020, 08:00 - 09:00 hrs

 

  • M. Smolinski (USA)
     

PLENARY

 

Plenary III

Room: Conference Hall 1 - 3

Saturday, February 22, 2020, 09:15 - 10:00 hrs

Chair: M. Mendelson (South Africa)

  • Collaborating with the Innate Immune System to Control Antibiotic-Resistant Superbugs – V. Nizet (USA)

 

PARALLEL SYMPOSIA


 

Malaysia’s Hepatitis C Elimination Journey – Global Implications and Opportunities

Room: Conference Hall 1

Saturday, February 22, 2020, 10:30 – 12:00 hrs

(In collaboration with DNDi and FIND)

Chair: Datuk Dr Noor Hisham Abdullah (Malaysia)
 

  • Malaysia’s Hepatitis C Elimination Journey – Global Implications and Opportunities – Datuk Dr. Muhammad Radzi Abu Hassan (Malaysia)

  • Equitable and Sustainable Access to HCV Treatment – F. Bompart (Switzerland)

  • Innovation and Integration of HCV Diagnostics to Facilitate Linkage to Care –S. Shilton (Switzerland)

  • Options for Governments Using their Rights – C. Yoke Ling (Malaysia) 

Clinical Management of Multidrug Resistant Infections 

Room: Conference Hall 2

Saturday, February 22, 2020, 10:30 – 12:00 hrs

(In collaboration with ESCMID)

Co-chairs: M. Akova (Turkey), A. Adnan (Malaysia)

 

  • New Directions in the Management of Resistant GNRs – M. Akova (Turkey)

  • Gram-positive Cocci Resistance - Clinical Management – S. Kumar (Malaysia)

  • Drug Resistant Enteric Pathogens (including S. typhi) – P. Rupali (India)

 

Pandemic Preparedness – 25 Years of ProMED

Room: Conference Hall 3

Saturday, February 22, 2020, 10:30 – 12:00 hrs

(In collaboration with ProMED)

Co-chairs: L. Madoff (USA), L. MacKinnon (USA), M. Pollack (USA)

 

  • Declaration of Public Health Emergencies of International Concern (PHEIC) – Whether, When, and Why – R. Steffen (Switzerland)

  • Climate and Global Disease Outbreaks: The View from 36,000km – A. Anyamba (USA)

  • Innovative use of ProMED Data for Epidemiologic Insights – A. Desai (USA)

 

Oral Abstracts - Viral Infections

Room: 302 & 303

Saturday, February 22, 2020, 10:30 – 12:00 hrs
Co-chairs: G. Screaton (UK), A. Scagliarini (Italy)

  • A sentinel surveillance system for viral respiratory infections in children attending child care centres in Singapore - M. Zahari (SINGAPORE)

  • Antiviral prophylaxis is effective in reducing influenza outbreak severity in residential care - S. Fletcher-Lartey (AUSTRALIA)

  • Detection and genetic characterization of avian influenza A (H5N6) virus clade 2.3.4.4 in isolates from house crow and poultry in Bangladesh, 2017 -
    A. Islam (BANGLADESH)

  • Role of polymerase genes in the mammalian adaptation of H3N2v influenza virus - C. Pappas (USA)

  • The interaction between hepatitis C infection and risk of cardiovascular disease in Canadians: A Bayesian network modeling study - A. Badawi (CANADA)

  • Clinically relevant markers of infection revealed through population genetics: the example of cytomegalovirus infections - T. Kowalik (USA)

  • Enterovirus and Gut Virome Profile in Indian Infants and Immune Response to Oral Rotavirus Vaccine - I. Praharaj (INDIA)

  • Effect of systemic corticosteroid use on risk of herpes zoster in a population-based cohort study - J.Qian (AUSTRALIA)

 

The Global Rise of Sexually Transmitted Infections

Room: 304 & 305

Saturday, February 22, 2020, 10:30 – 12:00 hrs

(In collaboration with GARDP)

Co-chairs: C. Ferreyra (Switzerland), M. Levison (USA)

  • Public Health Driven Development of New Treatments for Multi-drug Resistant Gonorrhea – S. O'Brien (Switzerland)

  • Resurgence of Syphilis – D. Lewis (Australia)

  • Network Approach to Tracking the Dissemination of Sexually Transmitted Infections in the Community – S. S. Lee (Hong Kong)

 

WORKSHOP


 

ICID Feedback Session

Room: 302 & 303

Saturday, February 22, 2020, 12:30 – 13:45 hrs
 

In an ever-shrinking world, where infectious diseases spread to far-away regions faster than ever, international scientific exchange and cooperation remain important pillars to managing and controlling infectious diseases. The global spread of antibiotic resistance, emerging and re-emerging pathogens, and the need to rapidly diagnose and prevent the spread of infectious diseases further emphasize the importance of  international knowledge sharing and discovery in the field. Through digital resources and networks, physicians, microbiologists, and researchers can stay up to date with the newest developments in their field and are less dependent on medical congresses as a provider of knowledge and education. While medical congresses remain environments uniquely conducive to generating new ideas and solutions to problems, the role of the medical congress in spreading knowledge in the face of this changing environment needs to be re-examined.

 

Engage in an interactive session where you will meet colleagues from around the world. We want to learn what is important to YOU when attending an international congress and your input on how the ICID should evolve in the years to come.

This workshop is open to registered Congress attendees at no additional cost. No pre-registration is necessary.

Bring Your Manuscript 

Room: 304 & 305

Saturday, February 22, 2020, 12:30 – 13:45 hrs

 

  • E. Petersen (Denmark), Editor-in-Chief, International Journal of Infectious Diseases

  • J. McConnell (UK), The Lancet Infectious Diseases

  • R. Sarkar (UK), The Lancet Digital Health

  • L. Lutwick (USA), IDCases

  • S. McLellan (USA), Editor, International Journal of Infectious Diseases

  • S. Wasserman (South Africa), Assistant Editor, International Journal of Infectious Diseases

  • I. Praharaj (India), Assistant Editor, International Journal of Infectious Diseases
     

This workshop is open to registered Congress attendees at no additional cost. Click here to register.

PARALLEL SYMPOSIA


 

Leadership Skills Development:

Managerial Decision Making: Pitfalls and Remedies

Room: Conference Hall 1

Saturday, February 22, 2020, 14:00 – 15:30 hrs

Co-chairs: S. Wasserman (South Africa), A. Amir (Pakistan)

  • Managerial Decision Making: Pitfalls and Remedies – F. de Véricourt (Germany)

Panel Discussion: Antimicrobials - Access and Stewardship: How Do We Get the Balance Right?

Room: Conference Hall 2

Saturday, February 22, 2020, 14:00 – 15:30 hrs

(in collaboration with DNDi and GARDP)

Moderator: A. Holmes (UK)

 ​

  • What are the Key Components of Access and Stewardship – TBD

  • How to Manage Access and Stewardship in Antibiotic R&D?  – S. O’Brien (Switzerland)

  • Should we Introduce Mass Drug Administration of Azithromycin to reduce child mortality? – M. Mendelson (South Africa)

  • How to introduce new antimicrobials for Multidrug Resistant Pathogens in High-endemic Settings – P. Sirivongrangson (Thailand)

 

Global Action on Antimicrobial Resistance - New Control and Treatment Strategies

Room: Banquet Hall

Saturday, February 22, 2020, 14:00 – 15:30 hrs

(In collaboration with the Japanese Association for Infectious Diseases)

Co-chairs: K. Yanagihara (Japan), S. Amin Nordin (Malaysia)

 

  • International Comparison of Antibiotic-resistant Bacteria in Urinary Tract Infection – K. Shigemura (Japan)

  • Enhancing the International Coordination of Antimicrobial Resistance Research and Development – E. Nimmesgern (Germany)

  • Adjunctives and Alternatives to Antibiotics - Phages, Microbiome-modulating, Immune Approaches and Others – U. Theuretzbacher (Austria)

 

Oral Abstracts - Preventing Infectious Diseases

Room: 302 & 303

Saturday, February 22, 2020, 14:00 – 15:30 hrs

Co-chairs: TBD, R. Aziz (Egypt)

  • Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine compared to Egg-Based Trivalent High Dose and other Egg-Based Vaccines –

  • J. Mould (USA)

  • Influenza vaccine uptake and its effectiveness in preventing hospitalisations among Australian children with chronic lung diseases – N. Homaira (AUSTRALIA)

  • Five-year antibody persistence and boostability following PVRV ID post-exposure prophylaxis schedules in Filipinos exposed to suspected rabid animals – C. Ambas (PHILIPPINES)

  • A Sarawak Experience on the Use of IPC ID PEP Regimen In Patients Bitten By Laboratory Confirmed Rabies Animals – H.H. Chua (MALAYSIA)

  • MVA-BN Induces Protection Against Monkeypox in Non-Human Primates and has Favorable Immunological and Safety Profiles in Humans with a History of AIDS – T. Meyer (GERMANY)

  • Generating data for typhoid conjugate vaccine introductions in Africa - Results from the Severe Typhoid Fever Surveillance in Africa Program (SETA) –
    F. Marks (UNITED KINGDOM)

  • The contribution of host genetics and environmental variation to immune response in gamma-herpesvirus infections – N. Sallah (UNITED KINGDOM)

  • Development & implementation of a customized infection control program in South African Correctional Centres – A. Duse (SOUTH AFRICA)

Rabies - Key Areas of Focus for Successful Elimination

Room: 304 & 305

Saturday, February 22, 2020, 14:00 – 15:30 hrs

Co-chairs: C. Rupprecht (USA), P. Beldomenico (Argentina)

  • Do we Need Oral Bait Vaccination to Eliminate Dog Mediated Human Rabies? – G. Yale (India)

  • Mass Canine Vaccination: A Proven One Health Context for the Elimination of Human Rabies Caused by Dogs – U. R. Siddiqi (Bangladesh)

  • The Futility of Therapeutics and the Utility of Intradermal Immunization for Human Rabies Prophylaxis – A. Bastola (Nepal)

 

PLENARY

 

Plenary IV

Malaria

Room: Conference Hall 1 - 3

Saturday, February 22, 2020, 16:00 - 17:00 hrs

Chair: Z. Sekawi (Malaysia)

 

  • The Threat of Multidrug Resistant Falciparum Malaria – E. Ashley (Lao PDR)

  • Getting back on Track: the Tools and Strategies Needed to Achieve Malaria Elimination and Eradication – A. Ghani (UK)

  • Plasmodium knowlesi - Malaria at the One Health Interface – M.Y Fong (Malaysia)

Late Breaker Session: Panel Discussion: Wuhan nCoV Outbreak

Room: 304 & 305
Saturday, February 22, 2020, 17:15 - 18:15 hrs

Moderator: L. Madoff (USA)

  • George Gao (China)

  • Sylvie Briand (Switzerland)

  • Marjorie Pollack (USA)

  • Peter Daszak (USA)

  • Linfa Wang (Singapore)

  • TBD

 

Sunday, February 23, 2020

......................................................................................................................................................................

 

MEET THE EXPERT


 

Travel Medicine Updates


Room: 302 & 303

Sunday, February 23, 2020, 08:00 - 09:00 hrs

(in collaboration with the International Society of Travel Medicine)

 

  • L. H. Chen (USA), C. Coyle (USA)

 

Management of Infective Endocarditis 


Room: 304 & 305

Sunday, February 23, 2020, 08:00 - 09:00 hrs

 

  • K. M. J. Chan (Malaysia), TBD

Early Childhood Diarrheal Disease: Causes, Consequences, and Control 


Room: 301

Sunday, February 23, 2020, 08:00 - 09:00 hrs

 

  • TBD

 

PLENARY

 

Plenary V

Room: Conference Hall 2

Sunday, February 23, 2020, 09:15 - 10:00 hrs

Chair: B. Lassmann (USA)

 

  • Using Novel Data Sources to Tackle the Next Outbreak – A. Wesolowski (USA)

 

PARALLEL SYMPOSIA


 

Utilizing Newer Diagnostic Tests 

Room: Conference Hall 2

Sunday, February 23, 2020, 10:30 – 12:00 hrs

Co-chairs: S. Roberts (New Zealand), N. Ahmad (Malaysia)
 

  • Translating Genomics into Practice – D. Williamson (Australia)

  • Utilization of POC Tests and Biomarkers in Infectious Diseases in LMICs – S. Blacksell (Thailand)

  • The Lab of the Future: Artificial Intelligence and Microfluids – J. R. Manzano (UK)

 

Developing Vaccine Confidence

Room: Conference Hall 3

Sunday, February 23, 2020, 10:30 – 12:00 hrs

Co-chairs: A. Shet (USA), TBD
 

  • Vaccine Hesitancy in a Post-Fact World Including Role of Social Media and Other Drivers of Vaccine Hesitancy in High Income Countries – TBD

  • Vaccine Hesitancy from a Low/Middle Income Country Perspective Including Resurgence of Measles in the Philippines and the Issues Around the Dengue Vaccine Rollout in the Philippines – L. Bravo (Philippines)

  • The Relationship Between Vaccine Mandates and Vaccine Confidence – K. Attwell (Australia)

  • Q/A Session – A. Shet (USA)

 

Oral Abstracts - Bacterial Infections and Antimicrobial Resistance

Room: 302 & 303

Sunday, February 23, 2020, 10:30 – 12:00 hrs

Co-chairs: C.L. Leong (Malaysia), P. Brown (Jamaica)

  • Addressing Antimicrobial resistance in China: progress and challenges in translating political commitment into national action – N. Zhu (UNITED KINGDOM)

  • Development of an algorithm to prevent neonatal Healthcare-Associated Infections (HAIs): A Multimodal approach – U. Rani (INDIA)

  • Rectal colonization with multidrug-resistant Gram-negative bacteria:  prevalence and risk factors among pregnant women in Cape Town, South Africa – A.N.H. Bulabula (SOUTH AFRICA)

  • Antimicrobial Resistance Profile of Streptococcus pneumoniae in Children <5 Years of Age in Sea Nomads Population in Indonesia – W.O.D. Daningrat (INDONESIA)

  • Stool shedding of Salmonella Typhi in children with blood culture-confirmed typhoid fever –M. Srinivasan (INDIA)

  • Genomic insights into multi-drug and extensively drug resistant Klebsiella pneumoniae from India –C. Shankar (INDIA)

  • Carbapenem non-susceptibility associated with global transcriptional regulator MarA in Escherichia coli – S. Chetri (INDIA)

  • Cerebrospinal fluid MinION sequencing of 16S rRNA gene for rapid and accurate diagnosis of bacterial meningitis – H. Nguyen (VIET NAM)

Current Updates in Tuberculosis

Room: 304 & 305

Sunday, February 23, 2020, 10:30 – 12:00 hrs

Co-chairs: T. Brewer (USA), Y. Suputtamongkol (Thailand)
 

  • Next Generation ATP Synthase Inhibitors to Combat Drug Resistant Tuberculosis – G. Cook (New Zealand)

  • Tuberculosis at the Host Pathogen Interface – C. Ong (Singapore)

  • MDR-TB Treatment Update – S. Wasserman (South Africa)

 

PARALLEL SYMPOSIA


 

Neglected Tropical and Zoonotic Diseases

Room: Conference Hall 2

Sunday, February 23, 2020, 14:00 – 15:30 hrs

Co-chairs: R. Colebunders (Belgium), C. Ukaga (Nigeria)

  • The Role of Animal Reservoir in Spreading Human Leptospirosis in Southeast Asia – Z. Sekawi (Malaysia)

  • Melioidosis: Australia’s Greatest Mystery Export? – B. Currie (Australia)

  • Sarcocystis: From Snakes to Humans – K.T. Wong (Malaysia)

 

Hospital-Acquired Infections - How Much Can We Prevent?

Room: Conference Hall 3

Sunday, February 23, 2020, 14:00 – 15:30 hrs

Co-chairs: Z. Deris (Malaysia), M. Doll (USA)
 

  • HAIs - How Much Can We Prevent and How to Manage Expectations – G. Bearman (USA)

  • Screening Strategies in Different Resource Settings – N. Suwantarat (Thailand)

  • Candida auris – The Threat of Multidrug-resistant Nosocomial Fungi – L. Chai (Singapore)

 

Oral Abstracts - Hot Topics

Room: 302 & 303

Sunday, February 23, 2020, 14:00 – 15:30 hrs

Co-chairs: Y. Malik (Malaysia), A. Biswas (India)

  • Poverty and health among CDC plantation labourers in Cameroon: Perceptions, challenges and coping strategies – V.D. Makoge Epse Forbin (CAMEROON)

  • Development and evaluation of a mobile digital quiz game for the promotion of malaria awareness, positive perceptions and appropriate practices – U. Chukwuocha, (NIGERIA)

  • Cost-Effectiveness Analysis of PBO-LLINs compared to Non PBO LLINs in the reduction of Malaria among children in Jinja District – M. Kaakyo (UGANDA)

  • The utility of telephone helpline data for real-time syndromic surveillance of adverse events following immunization: Retrospective evaluation – Y. Mesfin (AUSTRALIA)

  • PEN-FAST: A validated penicillin allergy clinical decision rule - Implications for prescribing – J. Trubiano (AUSTRALIA)

  • Surveillance of serogroup B Neisseria meningitidis cases at United States colleges using the ProMED Mail platform – A. Srivastava, (USA)

  • Association of Cytomegalovirus Viremia with Pneumonia Severity in South African Children <5 Years of Age Enrolled in the PERCH Study – D. Moore (SOUTH AFRICA)

  • GeneXpert® Assay; and its Performance for the Diagnosis of HIV-associated Tuberculosis: Is Scale-Up worth It? – F. Rasheed (PAKISTAN)

Pediatric Infectious Diseases – Challenges and Opportunities

Room: 304 & 305

Sunday, February 23, 2020, 14:00 – 15:30 hrs

Co-chairs: C. Obiero (Kenya), T. Pinto (Brazil)
 

  • Optimizing Management of “Neonatal Sepsis” and our Path Towards Evidence-based Medicine – S. Saha (Bangladesh)

  • Re-emergence of Measles – TBD

  • Towards Eliminating HPV Associated Cancers: HPV Vaccination – Y.L Woo (Malaysia)

 

PLENARY

 

Plenary VI

Dengue

Room: Conference Hall 2

Sunday, February 23, 2020, 15:45 – 16:30 hrs

Chair: G. Malavige (Sri Lanka)
 

  • Innovations in Clinical Management of Dengue – B. Wills (Vietnam)

  • Dengue – Unusual Clinical Presentations – S. F. S. Omar (Malaysia)

  • ABUZZ: Citizen Science for Mosquito Monitoring – H. V. Narayanan (USA)